Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
State Legislation
#MarkupMadness
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
2022 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
Access! 2023 + IGBA 2023 Conference
- Last chance to register, join us in Orlando, FL on Feb 13-16!
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Releases
Share
Press Release
May 23, 2022
| Allen Goldberg
AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices
Press Release
May 16, 2022
| Allen Goldberg
Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council
Press Release
May 11, 2022
| Allen Goldberg
AAM Statement on House Energy and Commerce Health Subcommittee Markup of H.R. 7667 Reauthorizing Generic Drug and Biosimilar User Fee Amendments
Press Release
Apr 1, 2022
| Rachel Schwartz
HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries
Press Release
Feb 15, 2022
| Rachel Schwartz
AAM Statement on the Confirmation of Robert Califf to Lead FDA
Press Release
Feb 15, 2022
| Rachel Schwartz
Academy of Managed Care Pharmacy Named AAM’s 2022 Champion of Access
Press Release
Feb 14, 2022
| Rachel Schwartz
Chirag Patel Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Feb 14, 2022
| Rachel Schwartz
AAM Announces 2022 Board of Directors
Press Release
Feb 14, 2022
| Rachel Schwartz
AAM Announces 2022 Associate Members
Press Release
Feb 2, 2022
| Rachel Schwartz
AAM Statement on FDA User Fee Reauthorization
Press Release
Jan 24, 2022
| Rachel Schwartz
Avalere Analysis Finds Medicare Part D Patients Continue to Pay More for Generics
Press Release
Nov 19, 2021
| Rachel Schwartz
Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access
Load More
Advocacy
Issue Overview
#Rx4StateSavings
State Legislation
#MarkupMadness
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
2022 Savings Report
2022 Voices of Access Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Supply Chain Blueprint
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action